J.H. von der Thüsen
Leiden University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.H. von der Thüsen.
Arteriosclerosis, Thrombosis, and Vascular Biology | 2005
R. de Nooijer; C.J.N. Verkleij; J.H. von der Thüsen; J.W. Jukema; E. E. van der Wall; Th.J.C. van Berkel; A.H. Baker; E.A.L. Biessen
Background—Matrix metalloproteinase-9 (MMP-9) is involved in atherosclerosis and elevated MMP-9 activity has been found in unstable plaques, suggesting a crucial role in plaque rupture. This study aims to assess the effect of MMP-9 on plaque stability in apolipoprotein E-deficient mice at different stages of plaque progression. Methods and Results—Atherosclerotic lesions were elicited in carotid arteries by perivascular collar placement. MMP-9 overexpression in intermediate or advanced plaques was effected by intraluminal incubation with an adenovirus (Ad.MMP-9). A subset was coincubated with Ad.TIMP-1. Mock virus served as a control. Plaques were analyzed histologically. In intermediate lesions, MMP-9 overexpression induced outward remodeling, as shown by a 30% increase in media size (p=0.03). In both intermediate and advanced lesions, prevalence of vulnerable plaque morphology tended to be increased. Half of MMP-9–treated lesions displayed intraplaque hemorrhage, whereas in controls and the Ad.MMP-9/Ad.TIMP-1 group this was 8% and 16%, respectively (p=0.007). Colocalization with neovessels may point to neo-angiogenesis as a source for intraplaque hemorrhage. Conclusion—These data show a differential effect of MMP-9 at various stages of plaque progression and suggest that lesion-targeted MMP-9 inhibition might be a valuable therapeutic modality in stabilizing advanced plaques, but not at earlier stages of lesion progression.
Arteriosclerosis, Thrombosis, and Vascular Biology | 2009
R. de Nooijer; Ilze Bot; J.H. von der Thüsen; Michiel A. Leeuwenburgh; Herman S. Overkleeft; A.O. Kraaijeveld; R. Dorland; P. Van Santbrink; S.H. van Heiningen; Marijke M Westra; Petri T. Kovanen; J.W. Jukema; E. E. van der Wall; Th.J.C. van Berkel; Guo-Ping Shi; E.A.L. Biessen
Objective—A dysbalance of proteases and their inhibitors is instrumental in remodeling of atherosclerotic plaques. One of the proteases implicated in matrix degradation is cathepsin-S (CatS). To address its role in advanced lesion composition, we generated chimeric LDLr−/− mice deficient in leukocyte CatS by transplantation with CatS−/−×LDLr−/− or with LDLr−/− bone marrow and administered a high-fat diet. Methods and Results—No difference in aortic root lesion size could be detected between CatS+/+ and CatS−/− chimeras. However, leukocyte CatS deficiency markedly changed plaque morphology and led to a dramatic reduction in necrotic core area by 77% and an abundance of large foam cells. Plaques of CatS−/− chimeras contained 17% more macrophages, 62% less SMCs, and 33% less intimal collagen. The latter two could be explained by a reduced number of elastic lamina fractures. Moreover, macrophage apoptosis was reduced by 60% with CatS deficiency. In vitro, CatS was found to be involved in cholesterol metabolism and in macrophage apoptosis in a collagen and fibronectin matrix. Conclusion—Leukocyte CatS deficiency results in considerably altered plaque morphology, with smaller necrotic cores, reduced apoptosis, and decreased SMC content and collagen deposition and may thus be critical in plaque stability.
Atherosclerosis | 2010
R.A. van Dijk; Renu Virmani; J.H. von der Thüsen; Alexander F. Schaapherder; Jan H.N. Lindeman
BACKGROUND Risk factor profiles for the different vascular beds (i.e. coronary, carotid, peripheral and aortic) are remarkably different, suggesting that atherosclerosis is a heterogeneous disorder. Little is known about the morphologic progression of atherosclerosis in the peri-renal aorta, one of the primary predilection sites of atherosclerosis. METHODS A systematic analysis was performed in 260 consecutive peri-renal aortic patches (stained with Movat Pentachrome and H&E) collected during organ transplantation (mean donor age 46.5 (range 5-76) years; 54% male symbol; mean BMI 24.9; 40% smokers; 20% hypertensive). Plaque morphology was classified according to the modified AHA classification scheme proposed by Virmani et al. [4]. Immunostaining against CD68 was used to identify the distribution of intimal macrophages and monocytes in several predefined locations among various plaque types and fibrous cap thickness. RESULTS There was significant intimal thickening (p<0.013) and medial thinning (p<0.032) with advancing age. The incidence of atherosclerotic plaques in the abdominal aorta correlated with age (r=0.640, p=0.01). During the first three decades of life adaptive intimal thickening and intimal xanthomas were the predominant lesions. In contrast, the fourth, fifth and sixth decades hallmarked more complicated plaques of pathological intimal thickening, early and late fibroatheromas (EFAs and LFAs), thin-cap FAs (TCFAs; cap thickness <155 microm), ruptured plaques (PRs), healed rupture and fibrotic calcified plaques. The mean percentage of lesional macrophages increased significantly from LFAs to TCFAs (5-17%; p<0.001). Macrophage infiltration of the fibrous cap was negatively correlated with fibrous cap thickness (p<0.0004); TCFAs and PRs (caps<100 microm) contained significantly more macrophages (19%) compared with caps 101-300 microm (6%) and >300 microm (2%). Macrophages in shoulder regions were highest in early and late FAs ( approximately 45%) followed by TCFAs (27%) and PR (20%). Further, intimal vasa vasorum were mostly seen adjacent to the necrotic core of advanced atherosclerotic plaques and remained confined to the intimo-medial border despite marked thickening of the intima. CONCLUSION This study shows that peri-renal aortic atherosclerosis starts early in life. Gross plaque morphologies of the peri-renal abdominal aorta are similar to coronary atherosclerosis yet indications were found for site specific differences in macrophage content and neovascularization.
Atherosclerosis | 2012
Katrijn L. Rensing; J.H. von der Thüsen; Ester M. Weijers; F.M. Houttuijn Bloemendaal; G.W. van Lammeren; Aryan Vink; A.C. van der Wal; V.W.M. van Hinsbergh; C. M. van der Loos; Erik S.G. Stroes; P. Koolwijk; Th. B. Twickler
OBJECTIVE Exogenous insulin use in patients with type 2 diabetes (DM2) has been associated with an increased risk of cardiovascular events. Through which mechanisms insulin may increase atherosclerotic plaque vulnerability is currently unclear. Because insulin has been suggested to promote angiogenesis in diabetic retinopathy and tumors, we hypothesized that insulin enhances intra-plaque angiogenesis. METHODS An in vitro model of pathological angiogenesis was used to assess the potential of insulin to enhance capillary-like tube formation of human microvascular endothelial cells (hMVEC) into a three dimensional fibrin matrix. In addition, insulin receptor expression within atherosclerotic plaques was visualized in carotid endarterectomy specimens of 20 patients with carotid artery stenosis, using immunohistochemical techniques. Furthermore, microvessel density within atherosclerotic plaques was compared between 68 DM2 patients who received insulin therapy and 97 DM2 patients who had been treated with oral glucose lowering agents only. RESULTS Insulin, at a concentration of 10(-8)M, increased capillary-like tube formation of hMVEC 1.7-fold (p<0.01). Within human atherosclerotic plaques, we observed a specific distribution pattern for the insulin receptor: insulin receptor expression was consistently higher on the endothelial lining of small nascent microvessels compared to more mature microvessels. There was a trend towards an increased microvessel density by 20% in atherosclerotic plaques derived from patients using insulin compared to plaques derived from patients using oral glucose lowering agents only (p=0.05). CONCLUSION Exogenous insulin use in DM2 patients may contribute to increased plaque vulnerability by stimulating local angiogenesis within atherosclerotic plaques.
International Congress Series | 2004
Th.J.C. van Berkel; J.H. von der Thüsen; Johan Kuiper; E.A.L. Biessen; M. Van Eck
Atherosclerosis | 2010
Ilze Bot; S.C.A. de Jager; Martine Bot; S.H. van Heiningen; T. J. C. Van Berkel; J.H. von der Thüsen; E.A.L. Biessen
Cardiovascular Pathology | 2004
R de Nooijer; C.J.N Verkleij; J.H. von der Thüsen; A.H. Baker; Th.J.C. van Berkel; E.A.L. Biessen
Stp Pharma Sciences | 2002
E.A.L. Biessen; J.H. von der Thüsen; S. M. W. Van Rossenberg; Perry Prince; P. Van Santbrink; Martin K. Bijsterbosch; Johan Kuiper; T. J. C. Van Berkel
Archive | 2001
Th.J.C. van Berkel; E.A.L. Biessen; J.H. von der Thüsen; J.W.R. (Jos) Twisk; Johan Kuiper
Archive | 2001
Th.J.C. van Berkel; E.A.L. Biessen; J.H. von der Thüsen; J.W.R. (Jos) Twisk; Johan Kuiper